Jodie Pope Morrison - Aug 26, 2025 Form 4 Insider Report for Q32 Bio Inc. (QTTB)

Role: CEO, Director
Signature: /s/ Eric Bell, Attorney-in-Fact
Stock symbol: QTTB
Transactions as of: Aug 26, 2025
Transactions value $: -$18,900
Form type: 4
Date filed: 8/28/2025, 07:32 PM
Previous filing: Jul 28, 2025
Next filing: Dec 4, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Morrison Jodie Pope	CEO, Director	Q32 BIO INC., 830 WINTER STREET, WALTHAM	/s/ Eric Bell, Attorney-in-Fact	2025-08-28	0001618247

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	QTTB	Common Stock	Sale	-$18.9K	-10.5K	-7.95%	$1.80	122K	Aug 26, 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
F2	The price reported is a weighted average price. The securities were sold in multiple transactions over two consecutive trading days, at per share prices ranging from $1.81 to $1.96 and $1.73 to $1.83, respectively. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 2.

Content

Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.

The price reported is a weighted average price. The securities were sold in multiple transactions over two consecutive trading days, at per share prices ranging from $1.81 to $1.96 and $1.73 to $1.83, respectively. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote 2.